A detailed history of Gam Holding Ag transactions in Dexcom Inc stock. As of the latest transaction made, Gam Holding Ag holds 49,791 shares of DXCM stock, worth $3.58 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
49,791
Previous 57,299 13.1%
Holding current value
$3.58 Million
Previous $7.95 Million 28.97%
% of portfolio
0.46%
Previous 0.6%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$110.31 - $140.45 $828,207 - $1.05 Million
-7,508 Reduced 13.1%
49,791 $5.65 Million
Q1 2024

May 13, 2024

SELL
$114.22 - $140.1 $312,962 - $383,874
-2,740 Reduced 4.56%
57,299 $7.95 Million
Q4 2023

Jan 23, 2024

SELL
$75.49 - $124.16 $1.89 Million - $3.1 Million
-24,975 Reduced 29.38%
60,039 $7.45 Million
Q3 2023

Oct 16, 2023

SELL
$86.06 - $137.93 $131,929 - $211,446
-1,533 Reduced 1.77%
85,014 $7.93 Million
Q2 2023

Jul 27, 2023

BUY
$112.47 - $130.98 $3.74 Million - $4.36 Million
33,264 Added 62.43%
86,547 $11.1 Million
Q1 2023

May 09, 2023

BUY
$104.0 - $122.92 $4.89 Million - $5.77 Million
46,980 Added 745.36%
53,283 $6.19 Million
Q4 2022

Feb 02, 2023

SELL
$84.98 - $122.67 $2,379 - $3,434
-28 Reduced 0.44%
6,303 $713,000
Q3 2022

Oct 19, 2022

SELL
$76.35 - $94.18 $283,105 - $349,219
-3,708 Reduced 36.94%
6,331 $510,000
Q2 2022

Jul 21, 2022

BUY
$67.99 - $132.89 $511,828 - $1 Million
7,528 Added 299.8%
10,039 $748,000
Q1 2022

May 06, 2022

SELL
$94.08 - $130.2 $90,599 - $125,382
-963 Reduced 27.72%
2,511 $1.28 Million
Q4 2021

Jan 26, 2022

SELL
$129.87 - $162.82 $59,740 - $74,897
-460 Reduced 11.69%
3,474 $1.87 Million
Q2 2021

Aug 09, 2021

SELL
$80.99 - $107.93 $323 - $431
-4 Reduced 0.1%
3,934 $1.68 Million
Q1 2021

May 10, 2021

BUY
$84.79 - $104.74 $242,160 - $299,137
2,856 Added 263.96%
3,938 $1.42 Million
Q4 2020

Feb 10, 2021

SELL
$78.0 - $104.5 $568,464 - $761,596
-7,288 Reduced 87.07%
1,082 $400,000
Q3 2020

Nov 06, 2020

BUY
$95.51 - $112.95 $859 - $1,016
9 Added 0.11%
8,370 $3.45 Million
Q2 2020

Aug 10, 2020

BUY
$62.68 - $105.34 $125 - $210
2 Added 0.02%
8,361 $3.39 Million
Q1 2020

May 12, 2020

BUY
$47.79 - $75.63 $382 - $605
8 Added 0.1%
8,359 $2.25 Million
Q4 2019

Feb 06, 2020

BUY
$36.62 - $57.29 $146 - $229
4 Added 0.05%
8,351 $1.83 Million
Q1 2019

May 10, 2019

BUY
$28.07 - $38.18 $234,300 - $318,688
8,347 New
8,347 $994,000
Q4 2018

Feb 08, 2019

SELL
$26.99 - $37.37 $168,876 - $233,824
-6,257 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$23.35 - $36.72 $33,483 - $52,656
1,434 Added 29.73%
6,257 $895,000
Q2 2018

Aug 09, 2018

BUY
$17.54 - $25.22 $84,595 - $121,636
4,823 New
4,823 $458,000
Q3 2017

Nov 14, 2017

SELL
$11.36 - $18.98 $52,290 - $87,364
-4,603 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
4,603
4,603 $337,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $27.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Gam Holding Ag Portfolio

Follow Gam Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.